Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02479178
Title A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck (iNSITE2)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors BIND Therapeutics
Indications

cervical cancer

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

cholangiocarcinoma

head and neck squamous cell carcinoma

bile duct carcinoma

Therapies

BIND-014

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Investigative Site: #20 Goodyear Arizona 85338 United States Details
Investigative Site: #42 Greenbrae California 94904 United States Details
Investigative Site: #39 Denver Colorado 80045 United States Details
Investigative Site: #34 Detroit Michigan 48201 United States Details
Investigative Site: #34 St. Louis Missouri 63110 United States Details
Investigative Site: #43 Las Vegas Nevada 89169 United States Details
Investigative Site: # 37 Oklahoma City Oklahoma 73104 United States Details
Investigative Site: # 33 San Antonio Texas 78229 United States Details
Investigative Site: #74 Arkhangelsk Russian Federation Details
Investigative Site: #75 Kazan 420029 Russian Federation Details
Investigative Site: #70 Moscow 115478 Russian Federation Details
Investigative Site: #80 Murmansk Russian Federation Details
Investigative Site: #81 Omsk Russian Federation Details
Investigative Site: #84 Saint Petersburg 198255 Russian Federation Details
Investigative Site: #85 Saint Petersburg 198255 Russian Federation Details
Investigative Site: #73 Saint Petersburg Russian Federation Details
Investigative Site: #78 Saint Petersburg Russian Federation Details
Investigative Site: #79 Saint Petersburg Russian Federation Details
Investigative Site: #88 Saratov 410053 Russian Federation Details
Investigative Site: #77 Sochi Russian Federation Details
Investigative Site: #72 Ufa 450054 Russian Federation Details
Investigative Site: #87 Ul'yanovsk Russian Federation Details
Investigative Site: #82 Yaroslavl Russian Federation Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field